SUBSCRIBE

Breaking News on Contract Research, Manufacturing & Clinical Trials

Hot Topics > Consolidation

Consolidation

Consolidation

The pharmaceutical industry seems besieged on all sides by declining R&D productivity, expiring patents and relentless downward pricing pressure. One effect of this onslaught has been an upsurge in the level of consolidation as industry players attempt to cut costs, expand research pipelines and lengthen geographic reach.

Pharm-Olam nabs PE investment amid 'market void' for mid-tier CROs

13-Feb-2017 - Pharm-Olam has secured an investment from Quad-C Management as the private equity firm eyes add-on acquisitions to complement organic growth.

Pharmaron acquires Xceleron as it looks to provide 'end-to-end' services

11-Jan-2017 - Pharmaron’s acquisition of Xceleron further supports early discovery, preclinical and clinical development with expanded radiolabeled sciences capabilities.

Out with the old, in with the new? Lonza sells peptide biz, Recipharm adds Indian ops

05-Jan-2017 - Recipharm receives approval to buy Kemwell’s Indian operations and PolyPeptides completes the acquisition of Lonza’s peptide business. Welcome to in-Pharmatechnologist’s 2017 M&A round-up.

Top CRO M&A activity of 2016

22-Dec-2016 - As 2016 comes to a close, Outsourcing-Pharma.com looks back at some of the major mergers and acquisitions from the past year.

News in brief

Evotec completes Cyprotex acquisition

15-Dec-2016 - Evotec AG has completed its previously announced acquisition of the preclinical contract research organization (CRO), Cyrotex.

News in brief

CMO Evonik acquires silica business for $630m

13-Dec-2016 - Evonik Industries AG has acquired the silica business from the US company J.M. Huber, expanding the company’s presence in North America and Asia.

Lonza confirms interest in Capsugel takeover

12-Dec-2016 - Lonza has confirmed it is interested in buying Capsugel. 

Private equity snags another CRO, Premier Research

17-Oct-2016 - Premier Research has become the most recent contract research organization (CRO) to receive funding from private equity as the industry looks for "like-minded" partners for the long run.

Is industry consolidation stifling pharma innovation?

12-Oct-2016 - In a year of “merger mania,” researchers suggest the elimination of competition is reducing innovation in the pharmaceutical industry.

Parexel to acquire functional service provider ExecuPharm

26-Sep-2016 - Parexel has entered into a definitive agreement to acquire ExecuPharm, a global functional service provider (FSP), in a deal that it said will add scale to meet growing demand.

ICON completes ClinicalRM acquisition

19-Sep-2016 - The acquisition, which was announced in June of this year, has been completed, expanding the company’s reach into government sponsored research.

'Nontraditional' CRO services diversifying revenue streams, says analyst

25-Aug-2016 - Currently, the top ten CROs represent more than half the market, and as the industry continues to grow analysts suggest companies expand revenue streams through “nontraditional” services offerings.

Bioclinica acquired by private equity firm

22-Aug-2016 - The international private equity firm, Cinven, is set to purchase Bioclinica, marking the company’s latest in a series of purchases as industry consolidation continues.

ABC Labs unified under newly formed EAG Laboratories

13-Jul-2016 - The independent lab network has combined 11 of its brands, including ABC Laboratories, to reside under a single company in order to “leverage cross functional capabilities,” says CEO.

Charles River acquires analytical CRO

28-Jun-2016 - Charles River Laboratories has acquired Blue Stream Laboratories, expanding the company’s biologic and biosimilar development capabilities.

PCI Pharma Services' new owners focused on growth

02-Jun-2016 - Partners Group, a private markets investment manager, has agreed to acquire global pharmaceutical services provider PCI Pharma Services citing “trends towards outsourcing.”

Charles River: 2016 to be 'robust year'

11-May-2016 - After reporting a successful FY16, Charles River expects a successful new year driven by customer demand and enhanced strategic partnerships.

Aptuit bolsters its preclinical services with Exquiron acquisition

21-Apr-2016 - Aptuit has acquired Swiss CRO Exquiron Biotech, enhancing its drug identification and validation services.

ICIG completes acquisition of Sandoz site

04-Apr-2016 - International Chemical Investors Group (ICIG) has completed its acquisition of Sandoz Industrial Products GmbH from Novartis Group.

Amgen selects Patheon as a 'strategic' manufacturing partner

15-Mar-2016 - The flexible manufacturing deal with Amgen is a departure from the standard transactional contract approach, according to Patheon.

Crown Bioscience acquires PreClinOmics, adds CVMD models to portfolio

09-Mar-2016 - Crown Bioscience has announced the acquisition of PreClinOmics, an in vivo preclinical company specializing in early research in cardiovascular and metabolic diseases (CVMD).

Synexus buys US trial site network for patient access; follows recent deals by Icon, PRA and PPD

07-Mar-2016 - Synexus has bought trial site network Research Across America (RAA) in a deal it claims will give its customers access to the US market and additional study participants.

Generics consolidation continues: Mylan to acquire Meda for $9.9bn

16-Feb-2016 - The generic pharmaceuticals company, Mylan, has announced its offer to buy the Swedish specialty pharma company, Meda, in a deal valued at $9.9 bn.

Amatsigroup buys Q Biologicals in 'fragmented' EU bio-services space

27-Jan-2016 - French CDMO Amatsigroup will offer complete biologics development services and expand its European presence through the acquisition of Q Biologicals.

'Merger mania' could leave strategic CROs vulnerable in 2016, says PwC

05-Jan-2016 - Mergers among Big Pharma companies will continue into 2016 leaving strategic CRO partnerships at risk, according to a report from PwC.

Key Industry Events